Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-30
DOI
10.1038/srep34478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?
- (2016) Suzanne E. Peterson et al. BIOESSAYS
- Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease
- (2016) Rodolfo Gonzalez et al. CELL TRANSPLANTATION
- New ISSCR guidelines: clinical translation of stem cell research
- (2016) Jonathan Kimmelman et al. LANCET
- Pluripotent stem cells progressing to the clinic
- (2016) Alan Trounson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines
- (2016) George Q. Daley et al. Stem Cell Reports
- Stem Cell Therapies in Clinical Trials: Progress and Challenges
- (2015) Alan Trounson et al. Cell Stem Cell
- Proof of Concept Studies Exploring the Safety and Functional Activity of Human Parthenogenetic-Derived Neural Stem Cells for the Treatment of Parkinson's Disease
- (2015) Rodolfo Gonzalez et al. CELL TRANSPLANTATION
- Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
- (2015) Steven D Schwartz et al. LANCET
- Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies
- (2015) Erin A Kimbrel et al. Regenerative Medicine
- Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo
- (2015) Alan D. Agulnick et al. Stem Cells Translational Medicine
- Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
- (2015) Shin Kawamata et al. Journal of Clinical Medicine
- Increased Risk of Genetic and Epigenetic Instability in Human Embryonic Stem Cells Associated with Specific Culture Conditions
- (2015) Ibon Garitaonandia et al. PLoS One
- Comparable Frequencies of Coding Mutations and Loss of Imprinting in Human Pluripotent Cells Derived by Nuclear Transfer and Defined Factors
- (2014) Bjarki Johannesson et al. Cell Stem Cell
- Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration
- (2014) Hoshimi Kanemura et al. PLoS One
- Concise Review: Parthenote Stem Cells for Regenerative Medicine: Genetic, Epigenetic, and Developmental Features
- (2014) Brittany Daughtry et al. Stem Cells Translational Medicine
- Human Neural Precursor Cells Promote Neurologic Recovery in a Viral Model of Multiple Sclerosis
- (2014) Lu Chen et al. Stem Cell Reports
- Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies
- (2013) E. Ratcliffe et al. BRITISH MEDICAL BULLETIN
- Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer
- (2013) Masahito Tachibana et al. CELL
- Genomic Instability in Pluripotent Stem Cells: Implications for Clinical Applications
- (2013) Suzanne E. Peterson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
- (2013) Andrew S Lee et al. NATURE MEDICINE
- Deriving dopaminergic neurons for clinical use. A practical approach
- (2013) Rodolfo Gonzalez et al. Scientific Reports
- Safety of Human Neural Stem Cell Transplantation in Chronic Spinal Cord Injury
- (2013) Katja M. Piltti et al. Stem Cells Translational Medicine
- Embryonic stem cell trials for macular degeneration: a preliminary report
- (2012) Steven D Schwartz et al. LANCET
- Highly Sensitive In Vitro Methods for Detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human iPS Cells
- (2012) Takuya Kuroda et al. PLoS One
- Balancing Tissue and Tumor Formation in Regenerative Medicine
- (2012) A. M. Bailey Science Translational Medicine
- Translation of Stem Cell Research: Points to Consider in Designing Preclinical Animal Studies
- (2012) Joyce Frey-Vasconcells et al. Stem Cells Translational Medicine
- Effects of cell number on teratoma formation by human embryonic stem cells
- (2011) Andrew S. Lee et al. CELL CYCLE
- Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in Culture
- (2011) Louise C. Laurent et al. Cell Stem Cell
- Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
- (2010) Amanda Sierra et al. Cell Stem Cell
- Defining the Probability that a Cell Therapy Will Produce a Malignancy
- (2010) Darwin J Prockop MOLECULAR THERAPY
- Ethical Issues in Stem Cell Research
- (2009) Bernard Lo et al. ENDOCRINE REVIEWS
- Propagation of Sinusoidal Electrical Waves along the Spinal Cord during a Fictive Motor Task
- (2009) C. A. Cuellar et al. JOURNAL OF NEUROSCIENCE
- Geron gets green light for human trial of ES cell–derived product
- (2009) Joe Alper NATURE BIOTECHNOLOGY
- Developing safe therapies from human pluripotent stem cells
- (2009) Melissa K Carpenter et al. NATURE BIOTECHNOLOGY
- High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective
- (2009) Lorrene A. Buckley et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies
- (2009) Hannes Hentze et al. Stem Cell Research
- Striatal volume differences between non-human and human primates
- (2008) Dali Yin et al. JOURNAL OF NEUROSCIENCE METHODS
- A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development
- (2007) Sally Robinson et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- HLA Homozygous Stem Cell Lines Derived from Human Parthenogenetic Blastocysts
- (2007) E.S. Revazova et al. Cloning Stem Cells
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started